Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation
Bone Marrow Transplant
.
2020 Apr;55(4):827-829.
doi: 10.1038/s41409-019-0586-1.
Epub 2019 Jun 11.
Authors
Midori Nakagaki
1
,
Elise Button
2
3
,
Amy Keating
2
,
Jodie Marsh
4
,
Chris Mitchell
4
,
Andrew Birchley
4
,
Glen A Kennedy
2
5
Affiliations
1
Royal Brisbane and Women's Hospital, Butterfield Street, Herston, QLD, 4029, Australia. midori.nakagaki@health.qld.gov.au.
2
Royal Brisbane and Women's Hospital, Butterfield Street, Herston, QLD, 4029, Australia.
3
School of Nursing, Queensland University of Technology, Victoria Park Road, Kelvin Grove, QLD, 4059, Australia.
4
The Townsville Hospital, Angus Smith Drive, Douglas, QLD, 4814, Australia.
5
Faculty of Medicine, The University of Queensland, 20 Weightman Street, Herston, QLD, 4006, Australia.
PMID:
31186515
DOI:
10.1038/s41409-019-0586-1
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Hematopoietic Stem Cell Transplantation*
Humans
Melphalan
Multiple Myeloma*
Stem Cell Transplantation
Transplantation Conditioning
Transplantation, Autologous
Substances
Melphalan